<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ELISA &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/elisa/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 06 Oct 2026 13:47:41 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.2</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>ELISA &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Immune Antibodies Linked to Stroke Recovery and Relapse Risk in Landmark Berlin Study</title>
		<link>https://bioengineer.org/immune-antibodies-linked-to-stroke-recovery-and-relapse-risk-in-landmark-berlin-study/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 13:47:41 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Atherosclerosis]]></category>
		<category><![CDATA[Autoantibodies]]></category>
		<category><![CDATA[cardiovascular risk]]></category>
		<category><![CDATA[ELISA]]></category>
		<category><![CDATA[functional outcome]]></category>
		<category><![CDATA[G protein-coupled receptors]]></category>
		<category><![CDATA[immunology]]></category>
		<category><![CDATA[ischemic stroke]]></category>
		<category><![CDATA[neurology]]></category>
		<category><![CDATA[PROSCIS-B]]></category>
		<category><![CDATA[regulatory autoantibodies]]></category>
		<category><![CDATA[stroke etiology]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=404273</guid>

					<description><![CDATA[A prospective Berlin study of 562 ischemic stroke patients finds that both high and low levels of autoantibodies targeting G protein-coupled receptors are associated with distinct patterns of stroke etiology, functional recovery, and recurrent cardiovascular risk.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">404273</post-id>	</item>
		<item>
		<title>A Simple Blood Protein Could Reveal How Aggressive Advanced Prostate Cancer Will Be</title>
		<link>https://bioengineer.org/a-simple-blood-protein-could-reveal-how-aggressive-advanced-prostate-cancer-will-be/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 12:35:33 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[biomarker]]></category>
		<category><![CDATA[British Journal of Cancer]]></category>
		<category><![CDATA[ELISA]]></category>
		<category><![CDATA[immunosuppression]]></category>
		<category><![CDATA[macrophages]]></category>
		<category><![CDATA[metastatic castration-resistant prostate cancer]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[progression-free survival]]></category>
		<category><![CDATA[Prostate Cancer]]></category>
		<category><![CDATA[soluble CD163]]></category>
		<category><![CDATA[sSIRPα]]></category>
		<category><![CDATA[tumor microenvironment]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=404156</guid>

					<description><![CDATA[Danish researchers report that elevated serum levels of the macrophage-derived protein soluble CD163 independently predict shorter progression-free survival in metastatic castration-resistant prostate cancer, validated in an independent cohort.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">404156</post-id>	</item>
	</channel>
</rss>
